Get started
Author

Łukasz Joachimiak

Observed name: Lukasz Joachimiak
ORCID: 0000-0001-9962-2333
Observed ORCID: 0000-0001-9962-2333
OpenAlex ID: A5030740383
Aza-Michael Addition of Imidazole Analogues
2016 · Katarzyna Błażewska, Joanna Gmach, et al. · Synthesis · 43
Phosphorus-Based Probes as Molecular Tools for Proteome Studies: Recent Advances in Probe Development and Applications
2018 · Łukasz Joachimiak, Katarzyna M. Błażewska · Journal of Medicinal Chemistry · 41
Identification of the Privileged Position in the Imidazo[1,2-a]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors
2017 · Aleksandra Kaźmierczak, Damian Kusy, et al. · Journal of Medicinal Chemistry · 27
PDF
Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT
2014 · Fraser P. Coxon, Łukasz Joachimiak, et al. · European Journal of Medicinal Chemistry · 24
Synthesis and Biological Evaluation of Imidazole‐Bearing α‐Phosphonocarboxylates as Inhibitors of Rab Geranylgeranyl Transferase (RGGT)
2018 · Łukasz Joachimiak, Aleksandra Marchwicka, et al. · ChemMedChem · 13
Applying the prodrug strategy to α-phosphonocarboxylate inhibitors of Rab GGTase – synthesis and stability studies
2015 · Łukasz Joachimiak, Łukasz Janczewski, et al. · Organic & Biomolecular Chemistry · 12
Therapeutic inhibition of USP7 promotes antitumor immune responses
2025 · Angelika Muchowicz, Katarzyna M Głuchowska, et al. · Journal for ImmunoTherapy of Cancer · 10
PDF
Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin
2025 · Bardees M. Foda, Annika E. Baker, et al. · Frontiers in Pharmacology · 5
PDF
Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity
2026 · Jacek Chrzanowski, Julita Nowicka, et al. · Journal of Medicinal Chemistry · 2
Works count: 9
Citation count: 177
H-index: 7
I10-index: 7
Year
Topic
Type